Syneos Health, Inc. (SYNH) Does NOT Plan To Restate, PT To $62 At Baird
Tweet Send to a Friend
Baird analyst, Eric Coldwell, reiterated his Outperform rating on shares of Syneos (NASDAQ: SYNH) and raised his price target to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


